Future interventions that selectively modulate neutrophil activation, ROS generation, or NET formationsuch as PAD4 inhibitors, ROS scavengers, DNase-based therapies, or blockade of neutrophilplatelet interactionshold promise to shift PCOS management from symptomatic hormone modulation toward precision immuno-metabolic therapy
In South Australia, it is illegal to sell peptides, without a prescription, as outlined in the Controlled Substances Act 1984 (SA)
Short peptides are distinctive biomolecules that combine the benefits of traditional small molecules and mature proteins, offering new, more effective therapeutic agents with fewer side effects (Apostolopoulos et al., 2021
Campagna MC, Taketa T, Correa AM, Sudo K, Blum MA, Wadhwa R, Komaki R, Lee JH, Bhutani MS, Weston B, Liao ZX, Rice DC , Swisher S, Hofstetter WL, Ajani JA